Moderna ended the session at $254.19, up 5.27% from the previous close.
Large options trades in Moderna leaned bullish, with two prominent debit call spreads totaling approximately $2.55 million in net premium. Both structures used out-of-the-money calls expiring November 13, 2026, targeting a move into the $280.00–$297.50 zone while keeping risk defined. The positioning suggests disciplined upside participation rather than aggressive naked call buying.
>>Don’t Let Fees Quietly Eat Into Your Returns — Get up to SGD 200 in Options Rewards!
Options Indicators
Moderna currently has an implied volatility of 96.03%, and with an IV percentile of 87.65%, its options sit in an elevated volatility regime and are priced expensively relative to their own recent history. At the same time, the IV/HV ratio of 0.92 suggests implied volatility is running slightly below realized volatility, indicating the market is still assigning rich option premiums even though pricing is not dramatically stretched versus actual movement.
The Call/Put volume ratio is 1.43.
Large Trades
A bullish call spread with a net debit of $1.32 million was the largest displayed trade, built by buying 2,905 Nov. 13, 2026 $280.00 calls and selling 2,905 Nov. 13, 2026 $297.50 calls. Both strikes sit out of the money versus the $254.19 reference stock price, so this is a defined-risk upside structure rather than outright call chasing. The trader paid a net debit to position for a rise in MRNA toward and through the lower strike, while capping gains above $297.50, which points to a moderately bullish directional bet with controlled premium outlay.
A second displayed call combination, also structured as a call spread, carried a net debit of $1.23 million through double-sized legs: buying two blocks of 1,406 Nov. 13, 2026 $280.00 calls and selling two blocks of 1,406 Nov. 13, 2026 $297.50 calls. Since the package contains both buy calls and sell calls at different strikes, it likewise reflects a debit call spread designed to express upside exposure while offsetting part of the premium cost through the short higher-strike calls. With both strikes still out of the money, the strategic intent appears to be another measured bullish wager on a sizable advance into the 280.00–297.50 zone rather than an unlimited-upside breakout bet.
Overall, the large-trade flow leans bullish on MRNA. The dominant displayed orders were both net-debit call spreads concentrated in out-of-the-money strikes, showing traders were willing to pay premium for upside participation while keeping risk defined and financing part of the cost with short higher-strike calls. Even with some offsetting call-spread premium collection elsewhere in the broader block flow, the aggregate picture still favors a constructive outlook, suggesting institutions are positioning for upside over time but in a disciplined, target-driven way rather than through aggressive naked call buying.
Strategy Reference
For a low assignment probability, a seller could consider the Nov. 13, 2026 $200.00 put, which sits far below the $254.19 reference price and collects rich premium in the elevated IV environment; alternatively, traders seeking defined risk without posting large margin could use a vertical call spread such as the $280.00/$297.50 structure already seen in the flow.